High cost of devices and novel procedures in pipeline, which may provide better result than fluoroscopy are restraining growth of the digital fluoroscopy system market. For instance, endoscopic retrograde cholangioscopy procedure using spy glass rather than digital fluoroscopy to detect bile duct stones has completed phase three clinical trials in 2017, this is sponsored by Boston Scientific Corporation, a leading medical device company.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients